# Multiple Therapies in Treating Patients With Advanced Neuroblastoma

> **NCT00040872** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** monoclonal antibody 3F8
- **BIOLOGICAL:** sargramostim
- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** isotretinoin
- **DRUG:** thiotepa
- **DRUG:** topotecan hydrochloride
- **DRUG:** vincristine sulfate
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** drug resistance inhibition treatment
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** syngeneic bone marrow transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00040872
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040872, "Multiple Therapies in Treating Patients With Advanced Neuroblastoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00040872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*